Zobrazeno 1 - 10
of 127
pro vyhledávání: '"William B Slayton"'
Autor:
Zhongbo eHu, William B Slayton
Publikováno v:
Frontiers in Oncology, Vol 4 (2014)
Acute lymphoblastic leukemia bearing the Philadelphia chromosome is amongst the most difficult types of ALL to cure. However, the advent of targeted tyrosine kinase inhibitor (TKI) imatinib has ushered in a new era of treatments that have the potenti
Externí odkaz:
https://doaj.org/article/9daa751be7bd4d2e85e153e2444c492e
Autor:
Sung O Park, Heather L Wamsley, Kyungmi Bae, Zhongbo Hu, Xiaomiao Li, Se-woon Choe, William B Slayton, S Paul Oh, Kay-Uwe Wagner, Peter P Sayeski
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e59675 (2013)
Germline deletion of Jak2 in mice results in embryonic lethality at E12.5 due to impaired hematopoiesis. However, the role that Jak2 might play in late gestation and postnatal life is unknown. To understand this, we utilized a conditional knockout ap
Externí odkaz:
https://doaj.org/article/107094f9362e4f75bcb3a3f489558848
Autor:
Bradford S. Hoppe, Raymond B. Mailhot Vega, Nancy P. Mendenhall, Eric S. Sandler, William B. Slayton, Howard Katzenstein, Michael J. Joyce, Zuofeng Li, Stella Flampouri
Publikováno v:
International Journal of Particle Therapy, Vol 6, Iss 4, Pp 1-6 (2020)
Background: Local relapse is a predominant form of recurrence among pediatric patients with Hodgkin lymphoma (PHL). Although PHL radiotherapy doses have been approximately 20 Gy, adults with Hodgkin lymphoma receiving 30 to 36 Gy experience fewer in-
Externí odkaz:
https://doaj.org/article/e8df6e5ee94843579f76659bc71100d5
Autor:
Peter H Shaw, Jonathan Metts, Ernest Amankwah, Don E Eslin, Scott Bradfield, William B Slayton, Brian Hays, Brian Calkins, Juan Rico, Jeffrey Krischer
Publikováno v:
Cureus.
Autor:
Yong Yean Kim, William B. Slayton, Dhanashree Rajderkar, John D. Reith, Joanne Lagmay, Tung Wynn, John Fort
Publikováno v:
Radiology Case Reports, Vol 15, Iss 7, Pp 1110-1114 (2020)
Radiology Case Reports
Radiology Case Reports
Primary pulmonary artery sarcoma (PAS) is extremely rare in children. Nevertheless, distinguishing primary PAS from pulmonary embolism is critical to a child's survival. Primary PAS is commonly misdiagnosed as a pulmonary embolism due to similar pres
Autor:
Michael Joyce, Eric Sandler, William B. Slayton, Raymond B. Mailhot Vega, Bradford S. Hoppe, Zuofeng Li, Nancy P. Mendenhall, S. Flampouri, Howard M. Katzenstein
Publikováno v:
International Journal of Particle Therapy, Vol 6, Iss 4, Pp 1-6 (2020)
International Journal of Particle Therapy
International Journal of Particle Therapy
Background Local relapse is a predominant form of recurrence among pediatric patients with Hodgkin lymphoma (PHL). Although PHL radiotherapy doses have been approximately 20 Gy, adults with Hodgkin lymphoma receiving 30 to 36 Gy experience fewer in-f
Autor:
PETER H. SHAW, Jonathan L. Metts, Ernest K. Amankwah, Don E. Eslin, Scott M. Bradfield, William B. Slayton, Brian Hays, Brian Calkins, Juan F. Rico, Julio C. Barredo, Amy Smith, Iftikhar Hanif, Hector Rodriguez-Cortes, Ramamoorthy Nagasubramanian, Jeffrey Krischer
Publikováno v:
SSRN Electronic Journal.
Autor:
Shireen Vali, Christopher R. Cogle, Jan S. Moreb, Glenda G. Anderson, Vindhya Vijay, Neeraj Kumar Singh, John W. Hiemenz, Jatinder K. Lamba, Cesia Salan, Jack W. Hsu, Arati Khanna-Gupta, William B. Slayton, Kimberly E. Hawkins, Elizabeth Wise, Amy Meacham, Nosha Farhadfar, Christina Cline, Paul Castillo, Biljana Horn, Leylah Drusbosky, Taher Abbasi, Maxim Norkin, S. Radhakrishnan, Helen Leather, Caitlin Tucker, Yashaswini S Ullal, Madeleine Turcotte, Huzaifa Sikora, Prashant Ramachandran Nair, Leslie Pettiford, John R. Wingard, Hemant S. Murthy, Subharup Guha, Charlie C. Kim, Randy A. Brown, Anay Talawdekar
Publikováno v:
Blood Advances. 3:1837-1847
Patients with myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) are generally older and have more comorbidities. Therefore, identifying personalized treatment options for each patient early and accurately is essential. To address this,
Autor:
Lung-Ji Chang, Lujia Dong, Shih-Ting Tsao, Yuchen Liu, Wei Zhu, Jan S. Moreb, Sushmita Nair, William B. Slayton, Jing-Bo Wang
Publikováno v:
Current Gene Therapy. 19:40-53
Introduction: Recent studies on CD19-specific chimeric antigen receptor (CAR)-modified T cells (CARTs) have demonstrated unprecedented successes in treating refractory and relapsed B cell malignancies. The key to the latest CART therapy advances can
Publikováno v:
Pediatric Blood & Cancer. 68
Background Childhood acute lymphoblastic leukemia (ALL) survivors' increased risk for adverse health outcomes could be mitigated through consuming a balanced diet. Nonetheless, >70% of adult survivors do not meet survivorship dietary recommendations.